Drug Profile
Research programme: meningitis vaccine - Biological E Ltd
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Biological E Limited
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Meningococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Meningococcal-infections in India (Parenteral)
- 03 May 2007 Preclinical trials in Meningococcal infections in India (Parenteral)